Agilent to fund biotherapy incubator in India

By The Science Advisory Board staff writers

January 30, 2020 -- Agilent Technologies has announced a partnership with the Indian Institute of Technology (IIT) Delhi to advance biotherapeutic research in the country.

The institute aims to examine and report on biotherapeutic products for the Indian market. Under the agreement, Agilent will fund an incubator at IIT New Delhi that helps researchers establish best practices for identifying and characterizing biopharmaceuticals. The funding is part of Agilent's corporate social responsibility initiative to train researchers on protein characterization.

The incubator will be part of the Indian government's center of excellence for biopharmaceutical technology. The center will also perform protein analysis for startups that come out of the incubator.

Agilent unveils SureSelect DNA kit
Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research.
Software improves compatibility and efficiency in chromatography
On January 2, Thermo Fisher Scientific and Agilent Technologies announced their continued agreement to the industry-wide Instrument Control Exchange Program...

Copyright © 2020 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter